• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细针抽吸细胞学检查的甲状腺结节中 microRNA 表达谱:一项确证性系列研究。

MicroRNA expression profile of thyroid nodules in fine-needle aspiration cytology: a confirmatory series.

机构信息

Department of Medical, Surgical and Neurological Sciences, University of Siena, Siena, Italy.

出版信息

J Endocrinol Invest. 2019 Jan;42(1):97-100. doi: 10.1007/s40618-018-0880-6. Epub 2018 Mar 24.

DOI:10.1007/s40618-018-0880-6
PMID:29574528
Abstract

INTRODUCTION

MiRNAs are small endogenous non-coding RNAs implicated with gene expression regulation. Changes in miRNA levels have been reported in thyroid cancer. Fine-needle aspiration cytology (FNAC) is the most reliable tool for differential diagnosis of thyroid nodules.

METHODS

We have analyzed 174 FNAC from 168 patients with thyroid nodules for expression levels of 11 miRNAs (miRNA197; -187; -181b-3p; -181b-5p; -224; -181a; 146b; -221; -222; -155 and miRNA183) known to be up-regulated in cancer tissues compared to benign lesions. Expression of miRNAs was analyzed in FNA samples calculating the fold change of miRNA expression relative to normal thyroid tissue after normalization to an endogenous control.

RESULTS

In FNAC, miRNA expression was confirmed to be higher in malignant or suspicious for malignancy nodules compared to benign, only for miRNA146b, -222 and -221 (fold change expression ≥ 5).

CONCLUSION

In this study, we confirmed that a limited set of miRNAs can be used for the differential diagnosis of thyroid nodules.

摘要

简介

miRNAs 是小的内源性非编码 RNA,与基因表达调控有关。甲状腺癌中报道了 miRNA 水平的变化。细针穿刺细胞学(FNAC)是鉴别甲状腺结节的最可靠工具。

方法

我们分析了 168 例甲状腺结节患者的 174 例 FNAC,用于分析 11 种 miRNA(miRNA197;-187;-181b-3p;-181b-5p;-224;-181a;146b;-221;-222;-155 和 miRNA183)的表达水平,这些 miRNA 在癌症组织中与良性病变相比上调。在 FNA 样本中分析 miRNA 的表达,在标准化到内源性对照后,计算 miRNA 表达相对于正常甲状腺组织的倍数变化。

结果

在 FNAC 中,与良性结节相比,恶性或疑似恶性结节中 miRNA 的表达被证实更高,仅 miRNA146b、-222 和-221(表达倍数变化≥5)。

结论

在这项研究中,我们证实了一组有限的 miRNA 可用于甲状腺结节的鉴别诊断。

相似文献

1
MicroRNA expression profile of thyroid nodules in fine-needle aspiration cytology: a confirmatory series.细针抽吸细胞学检查的甲状腺结节中 microRNA 表达谱:一项确证性系列研究。
J Endocrinol Invest. 2019 Jan;42(1):97-100. doi: 10.1007/s40618-018-0880-6. Epub 2018 Mar 24.
2
MicroRNA expression profile helps to distinguish benign nodules from papillary thyroid carcinomas starting from cells of fine-needle aspiration.微 RNA 表达谱有助于从细针抽吸细胞中区分良性结节和甲状腺乳头状癌。
Eur J Endocrinol. 2012 Sep;167(3):393-400. doi: 10.1530/EJE-12-0400. Epub 2012 Jun 22.
3
Implications of a suspicious afirma test result in thyroid fine-needle aspiration cytology: an institutional experience.甲状腺细针穿刺细胞学检查中可疑阳性结果的意义:一项机构经验。
Cancer Cytopathol. 2014 Oct;122(10):737-44. doi: 10.1002/cncy.21455. Epub 2014 Aug 13.
4
Digital gene expression profiling of a series of cytologically indeterminate thyroid nodules.一系列细胞学检查结果不明确的甲状腺结节的数字基因表达谱分析
Cancer Cytopathol. 2015 Aug;123(8):461-70. doi: 10.1002/cncy.21564. Epub 2015 May 29.
5
Molecular Signature of Indeterminate Thyroid Lesions: Current Methods to Improve Fine Needle Aspiration Cytology (FNAC) Diagnosis.甲状腺结节的分子特征:改善细针穿刺活检(FNAC)诊断的当前方法
Int J Mol Sci. 2017 Apr 6;18(4):775. doi: 10.3390/ijms18040775.
6
Differentiating benign from malignant thyroid nodules using micro ribonucleic acid amplification in residual cells obtained by fine needle aspiration biopsy.应用细针抽吸活检获得的残余细胞中 micro ribonucleic acid 的扩增来区分甲状腺良性和恶性结节。
J Surg Res. 2013 Apr;180(2):216-21. doi: 10.1016/j.jss.2012.04.051. Epub 2012 May 14.
7
Diagnostic value of the candidate microRNAs in thyroid fine-needle aspiration biopsy (FNAB) samples.甲状腺细针穿刺活检样本中候选 microRNAs 的诊断价值。
Horm Mol Biol Clin Investig. 2020 Mar 13;41(2):hmbci-2019-0027. doi: 10.1515/hmbci-2019-0027.
8
Molecular Testing for miRNA, mRNA, and DNA on Fine-Needle Aspiration Improves the Preoperative Diagnosis of Thyroid Nodules With Indeterminate Cytology.细针穿刺获取物中miRNA、mRNA和DNA的分子检测可改善术前甲状腺结节的不确定细胞学诊断。
J Clin Endocrinol Metab. 2015 Jul;100(7):2743-50. doi: 10.1210/jc.2015-1158. Epub 2015 May 12.
9
[The frequency of malignant disease in cytological group of suspected cancer (ultrasound-guided fine-needle aspiration biopsy of nonpalpable thyroid nodules)].[疑似癌症细胞学组(超声引导下不可触及甲状腺结节细针穿刺活检)中恶性疾病的发生率]
Medicina (Kaunas). 2008;44(3):189-94.
10
A panel of four miRNAs accurately differentiates malignant from benign indeterminate thyroid lesions on fine needle aspiration.四组 miRNA 可准确地区分细针抽吸的恶性和良性甲状腺不定性病变。
Clin Cancer Res. 2012 Apr 1;18(7):2032-8. doi: 10.1158/1078-0432.CCR-11-2487. Epub 2012 Feb 20.

引用本文的文献

1
A systematic review of emerging RNA markers in thyroid fine needle aspiration cytology samples: advancements and challenges.甲状腺细针穿刺细胞学样本中新兴RNA标志物的系统评价:进展与挑战
Endocrine. 2025 May 9. doi: 10.1007/s12020-025-04266-z.
2
Insights in biomarkers complexity and routine clinical practice for the diagnosis of thyroid nodules and cancer.甲状腺结节和癌症诊断中生物标志物复杂性及常规临床实践的见解
PeerJ. 2025 Jan 20;13:e18801. doi: 10.7717/peerj.18801. eCollection 2025.
3
Investigation of the alterations in miRNA expression levels in thyroid nodules and malignancies.

本文引用的文献

1
The role of microRNAs in different types of thyroid carcinoma: a comprehensive analysis to find new miRNA supplementary therapies.微小 RNA 在不同类型甲状腺癌中的作用:全面分析以寻找新的 miRNA 补充治疗方法。
J Endocrinol Invest. 2018 Mar;41(3):269-283. doi: 10.1007/s40618-017-0735-6. Epub 2017 Jul 31.
2
The combination of four molecular markers improves thyroid cancer cytologic diagnosis and patient management.四种分子标志物的联合应用可改善甲状腺癌的细胞学诊断及患者管理。
BMC Cancer. 2015 Nov 19;15:918. doi: 10.1186/s12885-015-1917-2.
3
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.
甲状腺结节和恶性肿瘤中 miRNA 表达水平变化的研究。
Updates Surg. 2024 Oct;76(6):2329-2335. doi: 10.1007/s13304-024-01978-1. Epub 2024 Sep 6.
4
Cyto-Histological Profile of MicroRNAs as Diagnostic Biomarkers in Differentiated Thyroid Carcinomas.细胞组织学特征分析 miRNA 在分化型甲状腺癌中的诊断生物标志物。
Genes (Basel). 2024 Mar 21;15(3):389. doi: 10.3390/genes15030389.
5
Effective Use of microRNA, BRAF and Sonographic Risk Assessment in Bethesda III Thyroid Nodules Requires a Different Approach to Nodules with Features of Nuclear Atypia and Other Types of Atypia.在贝塞斯达Ⅲ类甲状腺结节中有效利用微小RNA、BRAF和超声风险评估,对于具有核异型性特征和其他异型性类型的结节需要采用不同的方法。
Cancers (Basel). 2023 Aug 27;15(17):4287. doi: 10.3390/cancers15174287.
6
Differential microRNA expression for diagnosis and prognosis of papillary thyroid cancer.用于甲状腺乳头状癌诊断和预后的微小RNA差异表达
Front Med (Lausanne). 2023 Apr 5;10:1139362. doi: 10.3389/fmed.2023.1139362. eCollection 2023.
7
The Importance of miRNA in the Diagnosis and Prognosis of Papillary Thyroid Cancer.微小RNA在甲状腺乳头状癌诊断和预后中的重要性
J Clin Med. 2021 Oct 15;10(20):4738. doi: 10.3390/jcm10204738.
8
Pregnancy-associated plasma protein A mRNA expression as a marker for differentiated thyroid cancer: results from a "surgical" and a "cytological" series.妊娠相关血浆蛋白 A mRNA 表达作为分化型甲状腺癌的标志物:一项“手术”和一项“细胞学”系列研究的结果。
J Endocrinol Invest. 2022 Feb;45(2):369-378. doi: 10.1007/s40618-021-01655-9. Epub 2021 Aug 4.
9
The changes in miR-221 and miR-222 before and after interventional therapy of coronary heart disease and analysis of their correlation with inflammatory factors and prognosis.冠心病介入治疗前后miR-221和miR-222的变化及其与炎症因子和预后的相关性分析
Am J Transl Res. 2021 Apr 15;13(4):3731-3737. eCollection 2021.
10
Evaluating pre- and post-operation plasma miRNAs of papillary thyroid carcinoma (PTC) patients in comparison to benign nodules.评估甲状腺乳头状癌(PTC)患者手术前后的血浆 miRNA,并与良性结节进行比较。
BMC Cancer. 2019 Jul 15;19(1):690. doi: 10.1186/s12885-019-5849-0.
2015年美国甲状腺协会成人甲状腺结节和分化型甲状腺癌管理指南:美国甲状腺协会甲状腺结节和分化型甲状腺癌指南工作组
Thyroid. 2016 Jan;26(1):1-133. doi: 10.1089/thy.2015.0020.
4
Malignant risk stratification of thyroid FNA specimens with indeterminate cytology based on molecular testing.基于分子检测对甲状腺细针穿刺活检(FNA)标本进行具有不确定细胞学结果的恶性风险分层。
Cancer Cytopathol. 2015 Aug;123(8):471-9. doi: 10.1002/cncy.21554. Epub 2015 Apr 27.
5
MicroRNA expression profile helps to distinguish benign nodules from papillary thyroid carcinomas starting from cells of fine-needle aspiration.微 RNA 表达谱有助于从细针抽吸细胞中区分良性结节和甲状腺乳头状癌。
Eur J Endocrinol. 2012 Sep;167(3):393-400. doi: 10.1530/EJE-12-0400. Epub 2012 Jun 22.
6
MicroRNA expression profiling of thyroid tumors: biological significance and diagnostic utility.甲状腺肿瘤的微小RNA表达谱分析:生物学意义及诊断效用
J Clin Endocrinol Metab. 2008 May;93(5):1600-8. doi: 10.1210/jc.2007-2696. Epub 2008 Feb 12.